NCT00892281 - ORCA - Oracea® for Rosacea: A Community-based Assessment | Biotech Hunter

Enrollment

1,421

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Rosacea

Interventions

DRUG

doxycycline (Oracea®) 40 mg modified release as monotherapy

Take once daily in the morning

DRUG

doxycycline (Oracea®) 40 mg modified release as add-on therapy

Take once daily in the morning

Trial Locations (1)

REGISTRAT® - MAP1, Inc. (CRO), Lexington